Ibrutinib in Previously Treated Waldenström’s MacroglobulinemiaSteven P. Treon, Ranjana H. Advani, Christina Tripsas et al.|New England Journal of Medicine|2015Cited by 937
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myelomaPaul G. Richardson, Kenneth C. Anderson, Edie Weller et al.|Blood|2010Cited by 866
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failurePaul G. Richardson, Robert J. Soiffer, Marcie Riches et al.|Blood|2016Cited by 333
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantationCorey Cutler, Robert J. Soiffer, Mary M. Horowitz et al.|Blood|2008Cited by 155
Lenalidomide, Bortezomib, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: Encouraging Efficacy in High Risk Groups with Updated Results of a Phase I/II StudyPaul G. Richardson, Kenneth C. Anderson, Sagar Lonial et al.|Blood|2008Cited by 68